↓ Skip to main content

SciELO

Article Metrics

Supplementation and therapeutic use of vitamin D in patients with multiple sclerosis: Consensus of the Scientific Department of Neuroimmunology of the Brazilian Academy of Neurology

Overview of attention for article published in Arquivos de Neuro-Psiquiatria, February 2014
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • One of the highest-scoring outputs from this source (#9 of 502)
  • High Attention Score compared to outputs of the same age (88th percentile)
  • High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

blogs
1 blog
twitter
5 tweeters
facebook
4 Facebook pages

Citations

dimensions_citation
3 Dimensions

Readers on

mendeley
30 Mendeley
Title
Supplementation and therapeutic use of vitamin D in patients with multiple sclerosis: Consensus of the Scientific Department of Neuroimmunology of the Brazilian Academy of Neurology
Published in
Arquivos de Neuro-Psiquiatria, February 2014
DOI 10.1590/0004-282x20130252
Pubmed ID
Authors

Brum, Doralina Guimaraes, Comini-Frota, Elizabeth Regina, Vasconcelos, Claudia Cristina F., Dias-Tosta, Elza, Brum, Doralina Guimarães, Vasconcelos, Claúdia Cristina F., Doralina Guimarães Brum, Elizabeth Regina Comini-Frota, Claúdia Cristina F. Vasconcelos, Elza Dias-Tosta

Abstract

Multiple sclerosis (MS) is an inflammatory, autoimmune, demyelinating, and degenerative central nervous system disease. Even though the etiology of MS has not yet been fully elucidated, there is evidence that genetic and environmental factors interact to cause the disease. Among the main environmental factors studied, those more likely associated with MS include certain viruses, smoking, and hypovitaminosis D. This review aimed to determine whether there is evidence to recommend the use of vitamin D as monotherapy or as adjunct therapy in patients with MS. We searched PUBMED, EMBASE, COCHRANNE, and LILACS databases for studies published until September 9 th , 2013, using the keywords "multiple sclerosis", "vitamin D", and "clinical trial". There is no scientific evidence up to the production of this consensus for the use of vitamin D as monotherapy for MS in clinical practice.

Twitter Demographics

The data shown below were collected from the profiles of 5 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 30 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Brazil 3 10%
Mexico 1 3%
Unknown 26 87%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 10 33%
Student > Master 5 17%
Student > Postgraduate 4 13%
Student > Doctoral Student 4 13%
Professor 3 10%
Other 4 13%
Readers by discipline Count As %
Medicine and Dentistry 19 63%
Nursing and Health Professions 5 17%
Agricultural and Biological Sciences 3 10%
Pharmacology, Toxicology and Pharmaceutical Science 1 3%
Chemistry 1 3%
Other 1 3%

Attention Score in Context

This research output has an Altmetric Attention Score of 12. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 May 2016.
All research outputs
#1,015,604
of 11,343,411 outputs
Outputs from Arquivos de Neuro-Psiquiatria
#9
of 502 outputs
Outputs of similar age
#20,929
of 183,627 outputs
Outputs of similar age from Arquivos de Neuro-Psiquiatria
#1
of 10 outputs
Altmetric has tracked 11,343,411 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 91st percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 502 research outputs from this source. They receive a mean Attention Score of 2.4. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 183,627 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 88% of its contemporaries.
We're also able to compare this research output to 10 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them